Radiotherapy may increase the long-term risk of death from cardiovascular disease, especially in women with left-sided breast cancer who are treated with contemporary tangential breast or chest-wall radiotherapy, according to a study in the Jan. 25 issue of the Journal of the American College of Cardiology.
THURSDAY, Jan. 20 (HealthDay News) -- Radiotherapy may increase the long-term risk of death from cardiovascular disease, especially in women with left-sided breast cancer who are treated with contemporary tangential breast or chest-wall radiotherapy, according to a study in the Jan. 25 issue of the Journal of the American College of Cardiology.
Kim Bouillon, M.D., M.P.H., from the Universite Paris-Sud in Villejuif, France, and colleagues studied 4,456 women diagnosed with breast cancer between 1954 and 1984, who survived for at least five years after breast cancer radiotherapy treatment. Participants were followed for an average of 28 years to assess mortality rates.
The investigators identified a total of 421 deaths due to cardiovascular diseases, 236 of which were due to cardiac disease. Women who had undergone radiotherapy had a 1.76-fold increased risk of dying from cardiac disease and a 1.33-fold increased risk of dying from vascular disease compared with those who had not received radiotherapy. Women who were treated for left-sided breast cancer had a 1.56-fold increased risk of death from cardiac disease compared with those treated for right-sided breast cancer. The relative risk increased with time after the diagnosis of breast cancer (P = 0.05).
"Our results confirm that radiotherapy for breast cancer, such as that practiced until the mid-1980s, increased the long-term risk of death from cardiac disease. The excess mortality due to cardiac disease was significantly higher following radiotherapy for left-sided than for right-sided breast cancer," the authors write.
AbstractFull Text (subscription or payment may be required)Editorial (subscription or payment may be required)
Related ContentTreatment Modalities for Female Genital Cancer (Radiotherapy) Survival rates same for conservation treatment or mastectomy for recurrent DCIS
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More